Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist

Transient receptor potential vanilloid 1 (TRPV1) channels contribute to the development of several chronic pain states and represent a possible therapeutic target in many painful disease treatment. Proinflammatory mediator bradykinin (BK) sensitizes TRPV1, whereas noxious peripheral stimulation incr...

Full description

Bibliographic Details
Main Authors: Eva Uchytilova, Diana Spicarova, Jiri Palecek
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/7/3712
_version_ 1797539064359944192
author Eva Uchytilova
Diana Spicarova
Jiri Palecek
author_facet Eva Uchytilova
Diana Spicarova
Jiri Palecek
author_sort Eva Uchytilova
collection DOAJ
description Transient receptor potential vanilloid 1 (TRPV1) channels contribute to the development of several chronic pain states and represent a possible therapeutic target in many painful disease treatment. Proinflammatory mediator bradykinin (BK) sensitizes TRPV1, whereas noxious peripheral stimulation increases BK level in the spinal cord. Here, we investigated the involvement of spinal TRPV1 in thermal and mechanical hypersensitivity, evoked by intrathecal (i.t.) administration of BK and an endogenous agonist of TRPV1, N-oleoyldopamine (OLDA), using behavioral tests and i.t. catheter implantation, and administration of BK-induced transient thermal and mechanical hyperalgesia and mechanical allodynia. All these hypersensitive states were enhanced by co-administration of a low dose of OLDA (0.42 µg i.t.), which was ineffective only under the control conditions. Intrathecal pretreatment with TRPV1 selective antagonist SB366791 prevented hypersensitivity induced by i.t. co-administration of BK and OLDA. Our results demonstrate that both thermal and mechanical hypersensitivity evoked by co-administration of BK and OLDA is mediated by the activation of spinal TRPV1 channels.
first_indexed 2024-03-10T12:40:04Z
format Article
id doaj.art-df9139c637d24bcf92a354126186f5ba
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T12:40:04Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-df9139c637d24bcf92a354126186f5ba2023-11-21T13:59:33ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01227371210.3390/ijms22073712Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 AntagonistEva Uchytilova0Diana Spicarova1Jiri Palecek2Laboratory of Pain Research, Institute of Physiology, Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech RepublicLaboratory of Pain Research, Institute of Physiology, Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech RepublicLaboratory of Pain Research, Institute of Physiology, Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech RepublicTransient receptor potential vanilloid 1 (TRPV1) channels contribute to the development of several chronic pain states and represent a possible therapeutic target in many painful disease treatment. Proinflammatory mediator bradykinin (BK) sensitizes TRPV1, whereas noxious peripheral stimulation increases BK level in the spinal cord. Here, we investigated the involvement of spinal TRPV1 in thermal and mechanical hypersensitivity, evoked by intrathecal (i.t.) administration of BK and an endogenous agonist of TRPV1, N-oleoyldopamine (OLDA), using behavioral tests and i.t. catheter implantation, and administration of BK-induced transient thermal and mechanical hyperalgesia and mechanical allodynia. All these hypersensitive states were enhanced by co-administration of a low dose of OLDA (0.42 µg i.t.), which was ineffective only under the control conditions. Intrathecal pretreatment with TRPV1 selective antagonist SB366791 prevented hypersensitivity induced by i.t. co-administration of BK and OLDA. Our results demonstrate that both thermal and mechanical hypersensitivity evoked by co-administration of BK and OLDA is mediated by the activation of spinal TRPV1 channels.https://www.mdpi.com/1422-0067/22/7/3712TRPV1bradykininOLDAspinal cordhyperalgesiaallodynia
spellingShingle Eva Uchytilova
Diana Spicarova
Jiri Palecek
Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
International Journal of Molecular Sciences
TRPV1
bradykinin
OLDA
spinal cord
hyperalgesia
allodynia
title Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
title_full Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
title_fullStr Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
title_full_unstemmed Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
title_short Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
title_sort hypersensitivity induced by intrathecal bradykinin administration is enhanced by n oleoyldopamine olda and prevented by trpv1 antagonist
topic TRPV1
bradykinin
OLDA
spinal cord
hyperalgesia
allodynia
url https://www.mdpi.com/1422-0067/22/7/3712
work_keys_str_mv AT evauchytilova hypersensitivityinducedbyintrathecalbradykininadministrationisenhancedbynoleoyldopamineoldaandpreventedbytrpv1antagonist
AT dianaspicarova hypersensitivityinducedbyintrathecalbradykininadministrationisenhancedbynoleoyldopamineoldaandpreventedbytrpv1antagonist
AT jiripalecek hypersensitivityinducedbyintrathecalbradykininadministrationisenhancedbynoleoyldopamineoldaandpreventedbytrpv1antagonist